AXS Investments LLC Takes $112,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

AXS Investments LLC bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,381 shares of the company’s stock, valued at approximately $112,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Aspire Private Capital LLC purchased a new position in GE HealthCare Technologies in the 2nd quarter worth approximately $26,000. Center for Financial Planning Inc. purchased a new position in GE HealthCare Technologies during the second quarter worth approximately $26,000. Larson Financial Group LLC acquired a new position in GE HealthCare Technologies during the second quarter worth $27,000. Sanctuary Wealth Management L.L.C. purchased a new stake in GE HealthCare Technologies in the 2nd quarter valued at $28,000. Finally, Silvant Capital Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth $29,000. Institutional investors and hedge funds own 79.18% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. Wells Fargo & Company initiated coverage on shares of GE HealthCare Technologies in a research report on Wednesday, August 16th. They set an “overweight” rating and a $90.00 price target on the stock. Citigroup assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, September 19th. They issued a “buy” rating and a $82.00 price target for the company. Bank of America began coverage on shares of GE HealthCare Technologies in a research report on Monday, July 31st. They set a “neutral” rating and a $82.00 price target on the stock. Finally, Argus assumed coverage on GE HealthCare Technologies in a report on Friday, August 25th. They issued a “buy” rating and a $80.00 price objective on the stock. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $88.44.

GE HealthCare Technologies Stock Up 1.5 %

Shares of NASDAQ GEHC opened at $73.00 on Monday. GE HealthCare Technologies Inc. has a 52-week low of $53.00 and a 52-week high of $87.83. The business’s 50 day moving average is $67.31 and its two-hundred day moving average is $73.26. The firm has a market cap of $33.23 billion and a price-to-earnings ratio of 21.73. The company has a quick ratio of 0.97, a current ratio of 1.25 and a debt-to-equity ratio of 1.44.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.10. GE HealthCare Technologies had a return on equity of 24.46% and a net margin of 8.91%. The firm had revenue of $4.82 billion for the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the previous year, the business earned $0.87 EPS. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. Research analysts predict that GE HealthCare Technologies Inc. will post 3.81 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Friday, October 20th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.16%. The ex-dividend date was Thursday, October 19th. GE HealthCare Technologies’s payout ratio is 3.57%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.